DeTTeCaK_GI2-CESPU-2025 - Decoding the toxicity and transgenerational effects of synthetic cathinones and ketamine enantiomers using C. elegans as a translational model.
admin-cespu
Principal Investigator:
Daniel José da Costa Barbosa
Leader Institution:
1H-TOXRUN - CESPU
Research Team:
Ana Filipa Fernandes Ferreira Sobral, Renata Sofia Araújo da Silva, Cristina Alexandra da Silva Mendes, Mariana Sofia Silva Carvalho, Maria João Duarte Hora
Funding entity:
CESPU
Budget:
5.500 €
Period covered:
01.09.2025 – 31.08.2026
Abstract:
The rising prevalence of New Psychoactive Substances (NPS), particularly synthetic cathinones and ketamine, is alarming. Synthetic cathinones are structurally diverse stimulants linked to multiorgan toxicity, while ketamine, often used as a racemic mixture, may exhibit enantiomer-specific pharmacodynamics, raising public health concerns due to their poorly characterized toxicological profiles. This project aims to characterize the organismal, cellular, and potentially transgenerational toxicity of prevalent synthetic cathinones [3-chloromethcathinone (3-CMC), 3-methylmethcathinone (3-MMC), 4-chloromethcathinone (4-CMC), ethcathinone, 4-chloroethcathinone (4-CEC), 4-chloro-α-pyrrolidinopropiophenone (4-Cl-α-PPP)] and ketamine [racemic mixture, and (R)- and (S)-ketamine], using Caenorhabditis elegans as a translational model organism. We will assess drug-induced effects on animal survival, development, locomotion and reproductive behaviours, and lifespan across different life stages. We expect to provide critical insights into age- and enantiomer-specific drug toxicity, addressing urgent knowledge gaps in NPS safety evaluation and offering translational relevance to human health.
The rising prevalence of New Psychoactive Substances (NPS), particularly synthetic cathinones and ketamine, is alarming. Synthetic cathinones are structurally diverse stimulants linked to multiorgan toxicity, while ketamine, often used as a racemic mixture, may exhibit enantiomer-specific pharmacodynamics, raising public health concerns due to their poorly characterized toxicological profiles. This project aims to characterize the organismal, cellular, and potentially transgenerational toxicity of prevalent synthetic cathinones [3-chloromethcathinone (3-CMC), 3-methylmethcathinone (3-MMC), 4-chloromethcathinone (4-CMC), ethcathinone, 4-chloroethcathinone (4-CEC), 4-chloro-α-pyrrolidinopropiophenone (4-Cl-α-PPP)] and ketamine [racemic mixture, and (R)- and (S)-ketamine], using Caenorhabditis elegans as a translational model organism. We will assess drug-induced effects on animal survival, development, locomotion and reproductive behaviours, and lifespan across different life stages. We expect to provide critical insights into age- and enantiomer-specific drug toxicity, addressing urgent knowledge gaps in NPS safety evaluation and offering translational relevance to human health.
Project area: